Visby Medical said that it has received 510(k) clearance and a CLIA waiver from the US Food and Drug Administration for its second-generation point-of-care sexual health test.
Chembio Diagnostics has obtained a CLIA waiver from the US Food and Drug Administration for its DPP HIV-Syphilis System, the firm announced on Friday.
To make fusion energy a viable resource for the world’s energy grid, researchers need to understand the turbulent motion of plasmas: a mix of ions and electrons swirling around in reactor vessels.
Q: What did you do with the other embryos? Were they implanted? A: There are seven couples but the clinical trial is on hold due to the current situation. Q: What did you to get feedback on the clinical trial design? What was the scope of th
When it comes toin vitrodiagnostic (IVD) technologies, medical device and diagnostic companies have been chomping at the bit to produce the next big innovation. The last few years have seen a surge in IVD technologies in the market, as devic
Its hard to believe its been a full year since Abbott closed its acquisition of Alere, considering what a contentious deal it was and how hard Abbott fought last year to get out of it. When the acquisition finally did close, Will All the Abb
Biodesix Makes the Case for VeriStrat Through New Study Biodesix通过新的研究证明了VeriStrat的可行性 The Biodesix VeriStrat test received an extra dose of validation last week through a 1,048-patient study published in the Oncol
✔ All (7)
✔ Press release (0)
✔ Industry news (7)
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.